Summary

Global inflation device market is expected to reach USD 1,264.48 million by 2032, from USD 862.07 million in 2024, growing at the CAGR of 4.9% in the forecast period of 2025 to 2032.
Market Segmentation:
Global Inflation Device Market, By Type (Analog Inflation Device and Digital Inflation Device), Capacity (20ml Inflation Device, 25ml Inflation Device, 30ml Inflation Device, and 60ml Inflation Device), Application (Interventional Cardiology, Peripheral Vascular Procedures, Interventional Radiology, Urological Procedures, Gastroenterological Procedures, and Others), Pressure (30 atm, 40 atm, 55 atm, and Others), Function (Stent Deployment and Fluid Delivery), End User (Hospitals, Interventional Laboratories, and Clinics), Distribution Channel (Direct Tender, Retail Sales, and Third Party Distributors), Country (U.S., Canada, Mexico, Germany, U.K., France, Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Philippines, Malaysia, Indonesia, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa) – Industry Trends and Forecast to 2032
Overview of Global Inflation Device Market Dynamics:
Driver
• Rising case of cardiovascular diseases
Restraint
• High cost of advanced inflation devices
Opportunity
• Expanding access to interventional care in emerging markets
Market Players
The key market players for global inflation device market are listed below:
• Boston Scientific Corporation
• BD
• B. Braun Interventional Systems Inc
• Olympus Corporation
• Merit Medical Systems
• Medtronic
• Teleflex Incorporated
• CONMED Corporation
• Integra LifeSciences Corporation
• Vygon SAS
• Atrion Medical
• Spectrum Medtech Pvt. Ltd
• Medorah Meditek Pvt. Ltd.
• SMT
• SURETECH MEDICAL INC.
• Cook
• Elite Medtek(Jiangsu) Co., Ltd
• Advin Health Care
• US Endovascular, LLC.
• ADVANCED LIFESCIENCES PVT. LTD.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.3 OVERVIEW OF THE GLOBAL INFLATION DEVICE MARKET 29
1.4 LIMITATIONS 30
1.5 MARKETS COVERED 31
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 DBMR TRIPOD DATA VALIDATION MODEL 36
2.6 MULTIVARIATE MODELLING 39
2.7 TYPE LIFELINE CURVE 39
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.9 DBMR MARKET POSITION GRID 41
2.10 VENDOR SHARE ANALYSIS 42
2.11 MARKET END USER COVERAGE GRID 43
2.12 SECONDARY SOURCES 44
2.13 ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 53
4.1 PESTAL ANALYSIS 55
4.2 COST ANALYSIS BREAKDOWN: GLOBAL INFLATION DEVICE MARKET 56
4.3 HEALTHCARE ECONOMY 57
4.3.1 HEALTHCARE EXPENDITURE 57
4.3.2 CAPITAL EXPENDITURE (CAPEX) 57
4.3.3 CAPEX TRENDS 57
4.3.4 CAPEX ALLOCATION 57
4.3.5 FUNDING SOURCES 57
4.3.6 INDUSTRY BENCHMARKS 57
4.3.7 HEALTHCARE EXPENDITURE RATIO IN OVERALL GDP 57
4.3.8 HEALTHCARE SYSTEM STRUCTURE 58
4.3.9 GOVERNMENT POLICIES 58
4.3.10 ECONOMIC DEVELOPMENT 58
4.4 INDUSTRY INSIGHTS 59
4.5 PENETRATION AND GROWTH PROSPECT MAPPING: GLOBAL INFLATION DEVICE MARKET 62
4.6 KEY PRICING STRATEGIES: GLOBAL INFLATION DEVICE MARKET 64
4.7 INNOVATION TRACKER AND STRATEGIC ANALYSIS: GLOBAL INFLATION DEVICE MARKET 66
4.8 OPPORTUNITY MAP ANALYSIS. 69
4.9 REIMBURSEMENT FRAMEWORK – GLOBAL INFLATION DEVICE MARKET 71
4.10 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR. 73
4.10.1 GLOBAL VS. REGIONAL TARIFF STRUCTURES 73
4.10.2 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY 73
4.10.3 TARIFF REGULATIONS IN KEY MARKETS 73
4.11 TARIFFS ON MEDICAL DEVICES & EQUIPMENT 74
4.11.1 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT 74
4.11.2 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY 74
4.11.3 CASE STUDIES OF TARIFF CHANGES AFFECTING THE INDUSTRY 74
4.11.4 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES 74
4.11.5 TARIFF EXEMPTIONS AND INCENTIVES 74
4.11.6 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES 74
4.11.7 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN 74
4.11.8 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS 75
4.12 TECHNOLOGY ROADMAP: GLOBAL INFLATION DEVICE MARKET 76
4.13 VALUE CHAIN ANALYSIS: GLOBAL INFLATION DEVICE MARKET 77
5 REGULATORY COMPLIANCE: GLOBAL INFLATION DEVICE MARKET 79
5.1 REGULATORY AUTHORITIES 79
5.2 REGULATORY SUBMISSIONS 80
5.3 INTERNATIONAL HARMONIZATION 80
5.4 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 81
5.5 REGULATORY CHALLENGES AND STRATEGIES 81
6 MARKET OVERVIEW 82
6.1 DRIVERS 84
6.1.1 RISING CASE OF CARDIOVASCULAR DISEASES 84
6.1.2 WIDE RANGE OF APPLICATIONS OF INFLATION DEVICES 84
6.1.3 INCREASING NUMBER OF MINIMALLY INVASIVE SURGERIES 85
6.1.4 AGING POPULATION AND CHRONIC DISEASE BURDEN 85
6.2 RESTRAINTS 87
6.2.1 HIGH COST OF ADVANCED INFLATION DEVICES 87
6.2.2 MAINTENANCE AND TRAINING REQUIREMENTS 87
6.3 OPPORTUNITIES 88
6.3.1 EXPANDING ACCESS TO INTERVENTIONAL CARE IN EMERGING MARKETS 88
6.3.2 TECHNOLOGICAL ADVANCEMENTS IN INFLATION DEVICES 88
6.3.3 STRATEGIC PARTNERSHIPS AND ACQUISITIONS 89
6.4 CHALLENGES 90
6.4.1 LOW-COST ALTERNATIVES OF INFLATION DEVICES 90
6.4.2 SHORTAGE OF HEALTHCARE PROFESSIONALS LIMITING DEVICE UTILIZATION 90
7 GLOBAL INFLATION DEVICE MARKET, BY TYPE 92
7.1 OVERVIEW 93
7.2 ANALOG INFLATION DEVICE 96
7.2.1 20ML INFLATION DEVICE 96
7.2.2 25ML INFLATION DEVICE 96
7.2.3 30ML INFLATION DEVICE 97
7.2.4 60ML INFLATION DEVICE 97
7.3 DIGITAL INFLATION DEVICE 97
7.3.1 30ML INFLATION DEVICE 98
7.3.2 25ML INFLATION DEVICE 98
7.3.3 20ML INFLATION DEVICE 98
7.3.4 60ML INFLATION DEVICE 98
8 GLOBAL INFLATION DEVICE MARKET, BY CAPACITY 99
8.1 OVERVIEW 100
8.2 20ML INFLATION DEVICE 103
8.3 25ML INFLATION DEVICE 103
8.4 30ML INFLATION DEVICE 104
8.5 60ML INFLATION DEVICE 104
9 GLOBAL INFLATION DEVICE MARKET, BY PRESSURE 105
9.1 OVERVIEW 106
9.2 30 ATM 109
9.3 40 ATM 109
9.4 55 ATM 110
9.5 OTHERS 110
10 GLOBAL INFLATION DEVICE MARKET, BY APPLICATION 111
10.1 OVERVIEW 112
10.2 INTERVENTIONAL CARDIOLOGY 115
10.3 PERIPHERAL VASCULAR PROCEDURES 115
10.4 INTERVENTIONAL RADIOLOGY 116
10.5 UROLOGICAL PROCEDURES 116
10.6 GASTROENTEROLOGICAL PROCEDURES 117
10.7 OTHERS 117

11 GLOBAL INFLATION DEVICE MARKET, BY DISTRIBUTION CHANNEL 118
11.1 OVERVIEW 119
11.2 DIRECT TENDER 122
11.3 RETAIL SALES 122
11.4 THIRD PARTY DISTRIBUTORS 123
12 GLOBAL INFLATION DEVICE MARKET, BY END USER 124
12.1 OVERVIEW 125
12.2 HOSPITALS 128
12.3 INTERVENTIONAL LABORATORIES 128
12.4 CLINICS 129
13 GLOBAL INFLATION DEVICE MARKET, BY FUNCTION 130
13.1 OVERVIEW 131
13.2 STENT DEPLOYMENT 134
13.3 FLUID DELIVERY 134
14 GLOBAL INFLATION DEVICE MARKET, BY REGION 135
14.1 OVERVIEW 136
14.2 NORTH AMERICA 140
14.2.1 U.S. 144
14.2.2 CANADA 147
14.2.3 MEXICO 150
14.3 EUROPE 153
14.3.1 GERMANY 157
14.3.2 U.K. 160
14.3.3 FRANCE 163
14.3.4 ITALY 166
14.3.5 SPAIN 169
14.3.6 NETHERLANDS 172
14.3.7 BELGIUM 175
14.3.8 SWITZERLAND 178
14.3.9 RUSSIA 181
14.3.10 TURKEY 184
14.3.11 REST OF EUROPE 187
14.4 ASIA-PACIFIC 188
14.4.1 CHINA 192
14.4.2 JAPAN 195
14.4.3 INDIA 198
14.4.4 SOUTH KOREA 201
14.4.5 AUSTRALIA 204
14.4.6 SINGAPORE 207
14.4.7 MALAYSIA 210
14.4.8 INDONESIA 213
14.4.9 THAILAND 216
14.4.10 PHILIPPINES 219
14.4.11 REST OF ASIA-PACIFIC 222
14.5 MIDDLE EAST AND AFRICA 223
14.5.1 SAUDI ARABIA 227
14.5.2 SOUTH AFRICA 230
14.5.3 U.A.E. 233
14.5.4 EGYPT 236
14.5.5 ISRAEL 239
14.5.6 REST OF MIDDLE EAST AND AFRICA 242
14.6 SOUTH AMERICA 243
14.6.1 BRAZIL 246
14.6.2 ARGENTINA 249
14.6.3 REST OF SOUTH AMERICA 252
15 GLOBAL INFLATION DEVICE MARKET, COMPANY LANDSCAPE 253
15.1 COMPANY SHARE ANALYSIS: GLOBAL 253
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 254
15.3 COMPANY SHARE ANALYSIS: EUROPE 255
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 256
16 SWOT ANALYSIS 257
17 COMPANY PROFILE 258
17.1 BOSTON SCIENTIFIC CORPORATION 258
17.1.1 COMPANY SNAPSHOT 258
17.1.2 REVENUE ANALYSIS 259
17.1.3 COMPANY SHARE ANALYSIS 259
17.1.4 PRODUCT PORTFOLIO 260
17.1.5 RECENT DEVELOPMENT 260
17.2 BD 261
17.2.1 COMPANY SNAPSHOT 261
17.2.2 REVENUE ANALYSIS 261
17.2.3 COMPANY SHARE ANALYSIS 262
17.2.4 PRODUCT PORTFOLIO 262
17.2.5 RECENT DEVELOPMENT 262
 
17.3 B. BRAUN INTERVENTIONAL SYSTEMS INC. 263
17.3.1 COMPANY SNAPSHOT 263
17.3.2 COMPANY SHARE ANALYSIS 263
17.3.3 PRODUCT PORTFOLIO 264
17.3.4 RECENT DEVELOPMENT 265
17.4 OLYMPUS CORPORATION 266
17.4.1 COMPANY SNAPSHOT 266
17.4.2 REVENUE ANALYSIS 266
17.4.3 COMPANY SHARE ANALYSIS 267
17.4.4 PRODUCT PORTFOLIO 267
17.4.5 RECENT DEVELOPMENT 268
17.5 MERIT MEDICAL SYSTEMS 269
17.5.1 COMPANY SNAPSHOT 269
17.5.2 REVENUE ANALYSIS 269
17.5.3 COMPANY SHARE ANALYSIS 270
17.5.4 PRODUCT PORTFOLIO 270
17.5.5 RECENT DEVELOPMENTS 271
17.6 ADVANCED LIFESCIENCES PVT. LTD. 272
17.6.1 COMPANY SNAPSHOT 272
17.6.2 PRODUCT PORTFOLIO 272
17.6.3 RECENT DEVELOPMENT 274
17.7 ADVIN HEALTH CARE 275
17.7.1 COMPANY SNAPSHOT 275
17.7.2 PRODUCT PORTFOLIO 275
17.7.3 RECENT DEVELOPMENT 275
17.8 ATRION MEDICAL 276
17.8.1 COMPANY SNAPSHOT 276
17.8.2 REVENUE ANALYSIS 276
17.8.3 PRODUCT PORTFOLIO 277
17.8.4 RECENT DEVELOPMENT 277
17.9 CONMED CORPORATION 278
17.9.1 COMPANY SNAPSHOT 278
17.9.2 REVENUE ANALYSIS 278
17.9.3 PRODUCT PORTFOLIO 279
17.9.4 RECENT DEVELOPMENT 279
17.10 COOK 280
17.10.1 COMPANY SNAPSHOT 280
17.10.2 PRODUCT PORTFOLIO 280
17.10.3 RECENT NEWS 280

17.11 ELITE MEDTEK(JIANGSU) CO., LTD 281
17.11.1 COMPANY SNAPSHOT 281
17.11.2 PRODUCT PORTFOLIO 281
17.11.3 RECENT DEVELOPMENT 281
17.12 INTEGRA LIFESCIENCES CORPORATION 282
17.12.1 COMPANY SNAPSHOT 282
17.12.2 REVENUE ANALYSIS 282
17.12.3 PRODUCT PORTFOLIO 283
17.12.4 RECENT DEVELOPMENT 284
17.13 MEDORAH MEDITEK PVT. LTD. 285
17.13.1 COMPANY SNAPSHOT 285
17.13.2 PRODUCT PORTFOLIO 285
17.13.3 RECENT DEVELOPMENT 285
17.14 MEDTRONIC 286
17.14.1 COMPANY SNAPSHOT 286
17.14.2 REVENUE ANALYSIS 286
17.14.3 PRODUCT PORTFOLIO 287
17.14.4 RECENT DEVELOPMENT 287
17.15 SMT 288
17.15.1 COMPANY SNAPSHOT 288
17.15.2 PRODUCT PORTFOLIO 288
17.15.3 RECENT DEVELOPMENT 288
17.16 SPECTRUM MEDTECH PVT. LTD. 289
17.16.1 COMPANY SNAPSHOT 289
17.16.2 PRODUCT PORTFOLIO 289
17.16.3 RECENT DEVELOPMENT 289
17.17 SURETECH MEDICAL INC. 290
17.17.1 COMPANY SNAPSHOT 290
17.17.2 PRODUCT PORTFOLIO 290
17.17.3 RECENT DEVELOPMENT 290
17.18 TELEFLEX INCORPORATED 291
17.18.1 COMPANY SNAPSHOT 291
17.18.2 REVENUE ANALYSIS 291
17.18.3 PRODUCT PORTFOLIO 292
17.18.4 RECENT DEVELOPMENT 292
17.19 US ENDOVASCULAR, LLC. 293
17.19.1 COMPANY SNAPSHOT 293
17.19.2 PRODUCT PORTFOLIO 293
17.19.3 RECENT DEVELOPMENT 294

17.20 VYGON SAS 295
17.20.1 COMPANY SNAPSHOT 295
17.20.2 PRODUCT PORTFOLIO 295
17.20.3 RECENT DEVELOPMENT 295
18 QUESTIONNAIRE 296
19 RELATED REPORTS 300